Home / Stocks / ODTX

ODTX insider trading

Odyssey Therapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
7
Bought · 24 mo
$75.3M
Buys · last 90 days
0 · $0
Most recent buy
2026-05-13

Cluster buy detected

6 insiders bought ODTX within a short window (2026-05-08→2026-05-11), $75.3M in total — cluster score 70/100. Members see the buyers, the score breakdown and the chart.

See the cluster

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-05-13COULTER JAMES Gcluster
Insider
Bought1,388,889$18.00$25.0M
2026-05-12Dimension Capital II, L.P.cluster
Director
Bought1,111,111$18.00$20.0M
2026-05-11LEIDEN JEFFREY Mcluster
Director
Bought5,000$20.00$100k
2026-05-11Haas Jasoncluster
Chief Financial Officer
Bought1,000$20.00$20k
2026-05-11George Simeoncluster
10% owner
Bought555,555$18.00$10.0M
2026-05-11Li Nan (LN)cluster
Director
Bought1,111,111$18.00$20.0M
2026-05-11Chu Shelleycluster
Director
Bought11,111$18.00$200k

Most active insider buyers

InsiderRoleBuysTotal bought
COULTER JAMES GInsider1$25.0M
Dimension Capital II, L.P.Director1$20.0M
Li Nan (LN)Director1$20.0M
George Simeon10% owner1$10.0M
Chu ShelleyDirector1$200k
LEIDEN JEFFREY MDirector1$100k

See ODTX on the chart

Every insider buy and sell for ODTX plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.